You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Familial hemophagocytic lymphohistiocytosis (FLH)

Showing 1 - 25 of 938
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    Lymphoma-associated Hemophagocytic Lymphohistiocytosis

    Recruiting
    • Lymphoma
    • Hemophagocytic Lymphohistiocytoses
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jun 1, 2023

      Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

      Not yet recruiting
      • Carbapenem Resistant Bacterial Infection
      • Hemophagocytic Lymphohistiocytoses
      • Carrimycin tablets
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Aug 4, 2023

      EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

      Recruiting
      • EBV-associated Hemophagocytic Lymphohistiocytosis
      • EBV Infection
      • EBV-TCR-T cells
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Nov 12, 2023

      Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
      • Innsbruck, Austria
      • +9 more
      Oct 24, 2022

      PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

      Not yet recruiting
      • PD-1 Antibody
      • +3 more
      • L-DEP and PD-1 antibody
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Mar 8, 2023

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Sep 15, 2022

      Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

      Not yet recruiting
      • Refractory
      • +2 more
      • GTP regimen
      • (no location specified)
      Sep 8, 2023

      Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))

      Completed
      • Hemophagocytic Lymphohistiocytosis (HLH)
      • Paris, France
        Hôpital Necker-Enfants Malades
      Apr 13, 2021

      Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

      Recruiting
      • Hemophagocytic Lymphohistiocytoses
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Oct 25, 2022

        Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

        Active, not recruiting
        • Bone Marrow Failure Syndrome
        • +15 more
        • CD34 Stem Cell Selection Therapy
        • New York, New York
          Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
        Jun 17, 2020

        Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • +2 more
        • observational
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Dec 22, 2022

        Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis
        • Chronic Active Epstein-Barr Virus Infection
        • No intervention
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        May 2, 2023

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytosis
        • L-DEP and PD-1 antibody
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Apr 19, 2022

        IFN? and Inflammatory Mediators in Hemophagocytic

        Completed
        • Hemophagocytic Lymphohistiocytoses
        • Blood Draws Data Collection
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Sep 14, 2023

        Prospective Validation of the OHI Index

        Recruiting
        • HLH
        • +4 more
          • Kfar Saba, Israel
          • +1 more
          May 21, 2023

          Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

          Recruiting
          • Hemophagocytic Lymphohistiocytosis
          • DEP combine with PD-1 antibody
          • Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Feb 13, 2022

          HLH Trial in Beijing (Teniposide)

          Recruiting
          • HLH
          • Beijing, China
            Zhao Wang
          Sep 15, 2023

          Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

          Recruiting
          • Secondary Hemophagocytic Lymphohistiocytosis
          • Chronic Active Epstein-Barr Virus Infection
          • Rituximab Monotherapy
          • Beijing, China
            Zhao Wang
          May 18, 2022

          Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

          Withdrawn
          • Hemophagocytic Lymphohistiocytosis
          • Philadelphia, Pennsylvania
            Children's Hospital of Philadelphia
          Mar 11, 2022

          Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

          Not yet recruiting
          • Hemophagocytic Lymphohistiocytoses
          • Cytokine Storm
          • Hangzhou, Zhejiang, China
            The Children's Hospital of Zhejiang University School of Medicin
          Aug 4, 2022

          Hemophagocytic Lymphohistiocytosis Trial in Canada, United States (ATG, rabbit, Etoposide, Methotrexate)

          Completed
          Has Results
          • Hemophagocytic Lymphohistiocytosis
          • ATG, rabbit
          • +4 more
          • Phoenix, Arizona
          • +14 more
          Sep 21, 2020

          Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

          Recruiting
          • Hemophagocytic Lymphohistiocytosis
          • Phoenix, Arizona
          • +9 more
          Jan 9, 2023